▲
STOCKUPSIDE.IO
Analyst Price Target Intelligence
← Full Rankings
← Back to rankings
Ranked #4068 by analyst upside · 2026-10-16
OPCH
Option Care Health, Inc.
Healthcare · Market Cap $5B · P/E 23.7x
ANALYST PRICE TARGET
-3.8%
implied upside to consensus target
Current Price $31.22
Consensus Target $30.03
Bull Target $33.0
Bear Target $23.0
Analysts Covering 8
ANALYST CONSENSUS - HOLD
Strong Buy
0
Buy
0
Hold
8
Sell
0
52-Week Low $18.01
52-Week High $36.8
YTD Return -3.2%
FUNDAMENTALS
Market Cap $5B
P/E Ratio (TTM) 23.7x
Forward P/E 15.0x
EPS (TTM) $1.32
PEG Ratio 1.50
Dividend Yield N/A
Revenue (TTM) $5.7B
Profit Margin 3.7%
52-WEEK RANGE
52-Week Low $18.01
52-Week High $36.8
Current Price $31.22
Bear Target $23.0
Bull Target $33.0
● Now $31.22 ● Target $30.03
TRADING DATA
Avg Volume 3.8M
YTD Return -3.2%
Analyst Count 8
Consensus Hold
Upside to Target -3.8%
Last Updated 2026-10-16

ANALYST SUMMARY

Option Care Health, Inc. (OPCH) is currently trading at $31.22 with a Wall Street consensus price target of $30.03, which is 3.8% below the current price over the next 12 months. 8 analysts currently cover OPCH, with a consensus rating of Hold - 0% of analysts rate the stock a Buy or Strong Buy. The most bullish analyst has a price target of $33.0, while the most cautious has a target of $23.0.

OPCH operates in the Healthcare sector with a market capitalisation of $5B. The stock is down 3.2% year-to-date and is currently trading near the upper end of its 52-week range of $18.01 – $36.8.

SIMILAR STOCKS

Other Healthcare stocks with comparable size and valuation.

SHC +25.1%
Sotera Health Company
$5B · P/E 31.7x · Buy
STVN +27.1%
Stevanato Group S.p.A.
$5B · P/E 33.8x · Buy
MMSI +13.5%
Merit Medical Systems, Inc.
$5B · P/E 36.9x · Buy
LGND +15.3%
Ligand Pharmaceuticals Incorporated
$6B · P/E 32.4x · Buy
LIVN +15.3%
LivaNova PLC
$4B · P/E 23.2x · Buy

RECENT ANALYST CALLS

Upgrade/downgrade history for OPCH, with each firm's 90-day track record across all stocks we track. See full firm rankings →

UBS ↓ Downgrade
Buy → Neutral 2026-10-09 33% win rate (6 calls)
William Blair ↓ Downgrade
Outperform → Market Perform 2026-10-07 44% win rate (9 calls)
JP Morgan ↓ Downgrade
Overweight → Neutral 2026-10-07 43% win rate (7 calls)
Citizens ↓ Downgrade
Market Outperform → Market Perform 2026-10-07 Building track record
Jefferies ↓ Downgrade
Buy → Hold 2026-10-07 50% win rate (6 calls)
Barrington Research ↓ Downgrade
Outperform → Market Perform 2026-10-07 Building track record
Deutsche Bank ↓ Downgrade
Buy → Hold 2026-07-30 Building track record
Stephens & Co. ↓ Downgrade
Overweight → Equal-Weight 2026-07-17 Building track record
HISTORICAL SNAPSHOT

Point-in-time data from StockUpside's daily snapshots. Tracks price, analyst target, upside %, consensus, and analyst count.

Loading…
ANALYST CONVICTION SCORE
43
out of 100
Coverage depth
17/30
Consensus clarity
24/30
Vote unanimity
0/25
Rating stability
2/15

Measures analyst agreement, not fundamental quality. A high score means analysts broadly agree on this call - not that the stock will go up.

See 4,000+ stocks ranked by analyst upside

StockUpside.io tracks analyst consensus price targets across thousands of US-listed stocks, updated every day. The full ranked list is available with a Pro subscription.

View Full Rankings →